Live feed
Filing
SCHEDULE 13D
SCHEDULE 13D0000947871-25-000841·ORBIMED ADVISORS LLC
Schedule 13D ownership disclosure
Shattuck Labs Inc
Common Stock, par value $0.0001 per share · CUSIP: 82024L103
Event date: 2025-08-25
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ORBIMED ADVISORS LLCReported CIK 0001055951
Shares: 6,306,127.00 · Class: 9.99%
- OrbiMed Capital GP IX LLCReported CIK 0001920574
Shares: 5,255,106.00 · Class: 8.32%
- OrbiMed Genesis GP LLCReported CIK 0001808744
Shares: 1,051,021.00 · Class: 1.67%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-25-000841
- Form type
- SCHEDULE 13D
- Filer
- ORBIMED ADVISORS LLC
- CIK
- CIK 1055951
- Filed
- Sep 02, 2025
- Reporting period
- Aug 25, 2025
- Description
- Schedule 13D beneficial ownership